Clinical Trial of Boanmycin Hydrochloride With Docetaxel for Patients With Lung Squamous Cell Cancer as Chemotherapy

NCT01660399 · clinicaltrials.gov ↗

PHASE2

Phase

UNKNOWN

Status

300

Enrollment

OTHER

Sponsor class

Conditions

Squamous Cell Lung Cancer

Interventions

DRUG: Boanmycin
DRUG: Docetaxel

Sponsor

Tianjin Medical University Cancer Institute and Hospital